Physicians must apply to SAMHSA to provide buprenorphine treatment beyond the 30-patient limit for up to 100 patients with opioid dependency.
Physicians who have prescribed buprenorphine to 100 patients for at least one year can now apply to increase their patient limits to 275 under new federal regulations.
Modifying the number of patients a physician may treat under the Drug Addiction Treatment Act of 2000 (DATA 2000) is authorized under the Office of National Drug Control Policy Reauthorization Act of 2006. Physicians must apply to SAMHSA to treat more than 30 patients as well as meet the following conditions:
- Be currently authorized under DATA 2000 to prescribe buprenorphine products to up to 30 patients
- Complete the Online Notification Form to Increase Patient Limit at least one year after initial waiver was approved
Once you submit the form, you will receive an email indicating that your submission has been received. You must respond to this email to complete the submission process.
The SAMHSA Center for Substance Abuse Treatment (CSAT) will formally acknowledge your second notification submission by letter. Unless you are notified otherwise, this good faith submission automatically authorizes you to provide buprenorphine treatment to up to 100 patients.
For more information, contact CSAT's Buprenorphine Information Center at 866-BUP-CSAT (866-287-2728) or send an email to email@example.com.